Issuance of Paid Stock Options and Share-Based Compensation Stock Options
First written in FY2022. 3 of 5 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2025.
- FY2025AdvancedAnnual report
「Regarding the 11th Series Stock Acquisition Rights (stock options), 164,700 common shares」
The 11th Series of Stock Acquisition Rights granted in July 2025 vested during the fiscal year, with 164,700 shares subject to the rights for directors and directors of subsidiaries recorded as outstanding unexercised rights. - FY2024Partial expiration of stock optionsAnnual report
「Expired － － 50,000 Remaining unexercised 319,200 174,000 145,000」
50,000 shares underlying the ninth stock option plan in the form of stock-based compensation expired, reducing the number of remaining unexercised shares from 195,000 to 145,000. - FY2023-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Resolution date 27 February 2023 Classes and number of grantees* Directors of the company 4 Number of stock acquisition rights* 1,950 units (Note 1) Class, details and number of shares underlying the stock acquisition rights* Common shares: 195,000 shares (Note 1) Exercise period of the stock acquisition rights* 17 March 2023 to 16 March 2053」
The company disclosed the issuance of 1,950 stock options, representing 195,000 potential shares, to 4 directors under the ninth stock-based compensation stock option plan. - FY2023-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Directors of the company 4 Employees of the company (management) 4 Number of stock acquisition rights (units)* 1,740 units Class, details and number of shares underlying the stock acquisition rights* Common shares: 174,000 shares Exercise period of the stock acquisition rights* 16 March 2023 to 15 March 2033」
Regarding the eighth paid stock options, for which the resolution was disclosed in the previous report, the company disclosed the issuance of 1,740 options, representing 174,000 potential shares, to 4 directors and 4 managerial employees. - FY2022First statedAnnual report
「The Company resolved at a meeting of its Board of Directors held on 10 February 2023 to issue share acquisition rights. (Series 8 Share Acquisition Rights) (Paid Stock Options) Number of share acquisition rights (rights)* 1,740 Class, details and number of shares underlying the share acquisition rights (shares)* Common shares 174,000 Exercise period for the share acquisition rights* From 16 March 2023 to 15 March 2033 The Company resolved at a general meeting of shareholders held on 27 February 2023 to issue share acquisition rights. (Series 9 Share Acquisition Rights) (Stock Compensation-Type Stock Options) Number of share acquisition rights (rights)* 1,950 Class, details and number of shares underlying the share acquisition rights (shares)* Common shares 195,000 Exercise period for the share acquisition rights* From 17 March 2023 to 16 March 2053」
It disclosed that the Eighth Paid Stock Acquisition Rights and the Ninth Stock Compensation-Type Stock Acquisition Rights will be issued pursuant to resolutions of the Board of Directors and the General Meeting of Shareholders held after the filing.